Posts Tagged ‘New England Journal’

Advanced Skin, Brain Cancers Improve With Experimental Hedgehog Drug

3rd September 2009 by admin 3 Comments

People with advanced skin and brain cancers — untreatable by current methods — improve after treatment with a new oral drug called a hedgehog inhibitor.
Hedgehog is one of the hottest new anticancer targets. During embryonic development and childhood, the signaling molecule nicknamed hedgehog spurs growth processes. But the body turns it off during adulthood. When [...]

Study Finds Weight-Loss Surgery Safer Than Thought

30th July 2009 by admin No Comments

For those considering bariatric surgery to combat significant obesity, a new study suggests the risk of complications may be much lower than what has previously been reported.
The study, which looked at both gastric bypass surgery and laparoscopic adjustable gastric banding (lap-band surgery), found that the risk of death for these surgeries was 0.3 percent and [...]

Drug Shows Promise in Nervous-System Tumor Treatment

9th July 2009 by admin No Comments

U.S. researchers report the first successful drug treatment of tumors in patients with neurofibromatosis type 2 (NF2).
In people with NF2, benign tumors develop throughout the nervous system. The most common tumor is a vestibular schwannoma, which grows on the nerve connecting the ear to the brain. This type of tumor, also called acoustic neuroma, causes [...]

Changes Reduced Infections From Medical Abortion

9th July 2009 by admin 2 Comments

Two changes to the way Planned Parenthood clinics perform medical abortion resulted in a 93 percent drop in the rate of serious infections, a new report says.
The changes involved administering the drug misoprostol to the area between the gum and the cheek (buccal administration), not the vagina, and introducing routine treatment with antibiotics.
“Planned Parenthood is [...]

New Class of Drugs Promising for BRCA-Related Cancers

9th July 2009 by admin 1 Comment

New drugs called PARP inhibitors appear to have a lot of promise against hereditary cancers caused by BRCA1 and BRCA2 cell mutations.
PARP inhibitors work by blocking the action of poly (ADP-ribose) polymerase, an enzyme that helps repair DNA. In certain tumor cells, such as those from BRCA1 and BRCA2 mutation carriers, blocking this enzyme can [...]

Study Finds Abortion Pill Safe

11th June 2009 by admin 1 Comment

Though the first documented medical abortion in the U.S. dates back to 1950, it wasn’t until 2000 that the Food and Drug Administration approved the contentious medical-abortion drug, mifepristone (still commonly referred to by its clinical-trial designation, RU-486), as an alternative to the conventional surgical procedure. Since then, more than 500,000 U.S. women — and [...]

Study Suggests Drug Is Safe for Morning Sickness

11th June 2009 by admin 1 Comment

For the first time, a large study shows that pregnant women who suffer morning sickness are not risking harm to their babies if they take a certain anti-nausea drug. The result may lead more doctors to prescribe the drug metoclopramide and women to feel less guilty about using it during their baby’s crucial first few [...]